Menu Search
Equities

Synektik SA

SNT:WSE

Synektik SA

Actions
Health CareHealth Care Providers
  • Price (PLN)180.40
  • Today's Change0.00 / 0.00%
  • Shares traded14.79k
  • 1 Year change+191.91%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy2
Outperform2
Hold0
Sell0
Strong Sell0

Share price forecast in PLN

The 4 analysts offering 12 month price targets for Synektik SA have a median target of 194.50, with a high estimate of 214.00 and a low estimate of 75.00. The median estimate represents a 7.82% increase from the last price of 180.40.
High18.6%214.00
Med7.8%194.50
Low-58.4%75.00

Dividends in PLN

In 2023, Synektik SA reported a dividend of 3.03 PLN, which represents a significant increase over last year. The 3 analysts covering the company expect dividends of 3.80 PLN for the upcoming fiscal year, an increase of 25.41%.
Div growth (TTM)405.00%
More ▼

Earnings history & estimates in PLN

Synektik SA reported annual 2023 earnings of 4.06 per share on Feb 14, 2024.
Average growth rate+338.03%
More ▼

Revenue history & estimates in PLN

Synektik Spolka Akcyjna had 3rd quarter 2024 revenues of 123.98m. This bettered the 101.20m consensus of the 2 analysts covering the company. This was 13.79% below the prior year's 3rd quarter results.
Average growth rate+26.75%
Synektik Spolka Akcyjna had revenues for the full year 2021 of 128.63m. Last year the company did not report any revenues.
Average growth rate+24.27%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.